faq

FAQs

Where is Adhera Therapeutics headquartered?

8000 Innovation Parkway Baton Rouge LA 70820


Who are Adhera Therapeutics’ top executives?

Meet our management team.


Where is Adhera Therapeutics incorporated?

Adhera Therapeutics is incorporated in the State of Delaware.


When did Adhera Therapeutics go public?

Adhera Therapeutics went public in 1984 under the name “Nastech Pharmaceutical Company” and changed its name to “Adhera Therapeutics” on October 9, 2018.


Where does Adhera Therapeutics trade and what is the ticker symbol?

Adhera Therapeutics’ common stock is traded on the OTC PINK under the symbol “ATRX” (OTCQB change to OTC Pink)


When are quarterly financial results announced and how can I stay informed?

All events will be reported on this site within the time frame allotted by the SEC (45 days from the end of the quarter; 90 days from the end of the fiscal year December 31st), unless announced otherwise. Please see the event page for more information.


How do I invest in Adhera Therapeutics?

If you would like to purchase shares in Adhera Therapeutics, please contact your broker.


What is Adhera Therapeutics’ fiscal year?

Adhera Therapeutics’ fiscal year ends on December 31.


Who is Adhera Therapeutics’ transfer agent?

The transfer agent and registrar for the company’s common stock is:

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 718-921-8360
Fax: 718-765-8719


Does Adhera Therapeutics pay a dividend?

No, Adhera Therapeutics does not pay a dividend.


Does Adhera Therapeutics offer a Direct Stock Purchase Plan?

No, Adhera Therapeutics does not offer a Direct Stock Purchase Plan.


Where do I find SEC filings?

You can go to the official SEC site or you can follow this link to our page.


Who are Adhera Therapeutics’ independent auditors?

Salberg & Company, PA.

Scroll Up